Table 1.
Locus | Chr | SNP | Best p value | MAF control | MAF case | OR | SNP position |
---|---|---|---|---|---|---|---|
PTPN22* | 1 | rs6679677 | 3.2 × 10−25 | 0.10 | 0.14 | 1.59 | Intergenic |
ATP8B2-IL6R | 1 | rs11265608 | 2.8 10−8 | 0.10 | 0.12 | 1.33 | Intergenic |
STAT4 | 2 | rs10174238 | 1.3 × 10−13 | 0.23 | 0.28 | 1.29 | Intron |
IL2-IL21 | 4 | rs1479924 | 6.2 × 10−11 | 0.29 | 0.24 | 0.79 | Intergenic |
ANKRD55 | 5 | rs71624119 | 4.4 × 10−11 | 0.25 | 0.20 | 0.78 | Intron |
ERAP2-LNPEP | 5 | rs27290 | 7.5 × 10−9 | 0.44 | 0.47 | 1.32 | Intron |
C5orf56-IRF1 | 5 | rs4705862 | 1.0 × 10−8 | 0.44 | 0.39 | 0.84 | Intergenic |
HLA DQB1-DQA2* | 6 | rs7775055 | 3.1 × 10−174 | 0.02 | 0.12 | 6.01 | Intergenic |
IL2RA | 10 | rs7909519 | 8.0 × 10−10 | 0.11 | 0.08 | 0.72 | Intron |
FAS | 10 | rs7069750 | 2.9 × 10−8 | 0.44 | 0.48 | 1.18 | Intron |
SH2B3-ATXN2 | 12 | rs3184504 | 2.6 × 10−9 | 0.49 | 0.54 | 1.20 | Coding |
ZFP36L1 | 14 | rs12434551 | 1.6 × 10−8 | 0.47 | 0.43 | 0.77 | Intergenic |
PTPN2* | 18 | rs2847293 | 1.4 × 10−12 | 0.17 | 0.20 | 1.31 | Intergenic |
TYK2 | 19 | rs34536443 | 1.0 × 10−10 | 0.05 | 0.03 | 0.56 | Coding |
RUNX1 | 21 | rs9979383 | 1.1 × 10−8 | 0.37 | 0.33 | 0.78 | Intergenic |
UBE2L3 | 22 | rs2266959 | 6.2 × 10−9 | 0.19 | 0.22 | 1.24 | Intron |
IL2RB | 22 | rs2284033 | 1.6 × 10−8 | 0.44 | 0.39 | 0.84 | Intron |
Chr: chromosome; SNP: Single nucleotide polymorphism; MAF: Minor allele frequency; OR: Odds ratio.
indicates associations that had been described previously at genome wide levels of significance.
From Hinks A, Cobb J, Marion MC, Prahalad S, Sudman M, Bowes J, et al. Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritis. Nat Genet 2013; 45:664–9.